MILLET INNOVATION SA is a France-based company. It is a developer of medical and protective gear intended to cure orthopaedic and podiatric problems. The Company provides orthopaedic solutions such as joint, tendon, nerve, nail, and skin lesions, thereby providing comfort from disabling chronic pain. The Company distributes its products through its brand Epitact.

Employees

Sector

Drug Retailers

More about the company

Real-time Euronext Paris 08:00:11 23/10/2019 pm IST			5-day change	1st Jan Change
20.20 ^EUR	-.--%		-.--%	+18.82%

10/21/10	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
18/20/18	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI

Market Cap	3.85Cr 3.45Cr 3.17Cr 2.87Cr 5.37Cr 365.26Cr 5.47Cr 38Cr 15Cr 192.14Cr 14Cr 14Cr 605.93Cr	P/E 2017	17.4x	P/E 2018	19.8x
Enterprise Value	3.67Cr 3.29Cr 3.02Cr 2.74Cr 5.12Cr 348.62Cr 5.22Cr 36Cr 14Cr 183.38Cr 14Cr 13Cr 578.33Cr	EV / Sales 2017	1.97x	EV / Sales 2018	1.38x
Free-Float	5.42%	Yield 2017	3.36%	Yield 2018	-

10/21/10	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
18/20/18	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI
18/19/18	Curae Lab SARL agreed to acquire remaining 12.5% stake in Millet Innovation SA from Holding Managers for €4.8 million.	CI

25/19/25	Millet Innovation : MILLET INNOVATION - MISE EN OEUVRE DU RETRAIT OBLIGATOIRE
09/19/09	Millet Innovation : Communiqué de mise à disposition des Autres informations
08/19/08	Millet Innovation : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE D’INFORMATION ETABLI PAR CURAE LAB
18/19/18	Millet Innovation : DEPOT PROJET DE NOTE D’INFORMATION EN REPONSE RELATIVE A L’OPAS
17/19/17	Millet Innovation : RAPPORT SEMESTRIEL AU 30/06/2019

Millet Innovation Share Price

Stocks

ALINN

FR0010304402

Drug Retailers

Valuation: Millet Innovation

Latest news: Millet Innovation

News in other languages: Millet Innovation

Managers and Directors: Millet Innovation

Retail - Drugs without Grocery

Financials

Company Profile

Manager	Title	Age	Since
Damien Millet CEO	Chief Executive Officer	-	09/12/2002
Valérie Chopinet DFI	Director of Finance/CFO	-	19/12/2006

Director	Title	Age	Since
Jean-Claude Millet CHM	Chairman	-	16/03/1998
Pierre Martin BRD	Director/Board Member	-	16/03/1998
Jean-Paul Maingaud BRD	Director/Board Member	-	31/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MILLET INNOVATION	-.--%	-.--%	-	-	4.28Cr
JD HEALTH INTERNATIONAL INC.	+3.57%	+4.78%	-36.35%	+11.63%	1.55TCr
MATSUKIYOCOCOKARA & CO.	+0.75%	-1.26%	-5.83%	-0.76%	650.22Cr
TSURUHA HOLDINGS INC.	+1.81%	+1.13%	-15.32%	+2.87%	644.44Cr
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+1.77%	+1.05%	-50.85%	-38.70%	582.09Cr
RAIA DROGASIL S.A.	-1.81%	-24.95%	-22.38%	-37.48%	490.09Cr
YIFENG PHARMACY CHAIN CO., LTD.	+0.68%	+5.05%	+9.09%	-6.88%	481.98Cr
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+1.43%	+13.16%	+12.42%	-15.57%	346.66Cr
NAHDI MEDICAL COMPANY	-0.22%	+4.48%	-21.62%	-32.59%	314.88Cr
SUGI HOLDINGS CO.,LTD.	+0.61%	+3.88%	-21.88%	+28.97%	308.23Cr
Average	+0.86%	+0.46%	-16.97%	-9.83%	537.19Cr
Weighted average by Cap.	+1.54%	-0.14%	-21.50%	-5.88%

	2017	2018
Net sales	2.19Cr 1.96Cr 1.8Cr 1.63Cr 3.05Cr 207.55Cr 3.11Cr 21Cr 8.62Cr 109.18Cr 8.2Cr 8.03Cr 344.31Cr	2.22Cr 1.99Cr 1.83Cr 1.66Cr 3.1Cr 210.88Cr 3.16Cr 22Cr 8.76Cr 110.93Cr 8.33Cr 8.16Cr 349.83Cr
Net income	25.42L 22.77L 20.94L 18.98L 35.47L 24Cr 36.14L 2.5Cr 1Cr 13Cr 95.41L 93.39L 40Cr	16.33L 14.62L 13.45L 12.19L 22.78L 16Cr 23.2L 1.6Cr 64.38L 8.15Cr 61.27L 59.96L 26Cr
Net Debt	-10.66L -10L -9L -8L -14.87L -10Cr -15.15L -1.05Cr -42.03L -5.32Cr -39.99L -39.14L -17Cr	-17.52L -15.69L -14.44L -13.08L -24.45L -17Cr -24.91L -1.72Cr -69.11L -8.75Cr -65.76L -64.36L -28Cr